Category: Pharmaceuticals

Pharmaceuticals

Pitolisant Trial for Idiopathic Hypersomnia Ahead of Schedule

Harmony Biosciences announced an accelerated timeline for completing its phase 3 study evaluating pitolisant in adults idiopathic hypersomnia.

Pharmaceuticals

Avadel Seeks Final FDA Approval for Lumryz to Treat Narcolepsy

If approved, Avadel expects once-at-bedtime Lumryz to be the treatment of choice for patients with narcolepsy-related excessive daytime sleepiness or cataplexy.

Pharmaceuticals

Pitolisant Trialed for Obstructive Sleep Apnea in Japan

Aculys Pharma Inc has initiated a phase 3 clinical study in Japan of pitolisant in patients with OSA who have excessive daytime sleepiness.

Prescription Drugs

Idorsia Insomnia Medication QUVIVIQ Now Covered by TRICARE

"This is a big win for patients suffering from insomnia," says Patty Torr, Idorsia US president and general manager, in a release.

Over-the-Counter Treatments

Clinical Trial Compares Cannabinoids to Melatonin for Sleep Outcomes

Five cannabinoid products that all contained cannabidiol (CBD) were compared against a control product containing 5 mg of melatonin only.

Emerging Compounds

The Three Most Common Comorbidities in People with Narcolepsy

Two of the three narcolepsy comorbidities are well documented, but the third is likely new information for many physicians and patients.